Mohammad Ali Mashhadi
- Hematology top 10%
- Iron Metabolism and Disorders 8
- Chronic Myeloid Leukemia Treatments 5
-
- Hemoglobinopathies and Related Disorders 7
- Pathology and Forensic Medicine top 10%
- Chemotherapy-induced organ toxicity mitigation 6
- Vitamin D Research Studies 5
-
- Trace Elements in Health 6
-
- Gastric Cancer Management and Outcomes 5
-
- Acute Lymphoblastic Leukemia research 5
- Co-authors
- Mohammad HashemiMohsen TaheriEbrahim Eskandari‐NasabAliakbar FazaeliMohsen OmraniMahmoud Ali KaykhaeiZahra SepehriSeyed Mehdi Hashemi
- Cited by
- HematologyCancer ResearchGenetics
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (14 papers)PLoS ONE (1 paper)
In The Last Decade
Mohammad Ali Mashhadi
66 papers receiving 826 citations
Peers
Comparison fields: 5 of 92
- Hematology 117
- Cancer Research 154
- Genetics 76
- Pathology and Forensic Medicine 124
- Oncology 152
Countries citing papers authored by Mohammad Ali Mashhadi
This map shows the geographic impact of Mohammad Ali Mashhadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Ali Mashhadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Ali Mashhadi more than expected).
Fields of papers citing papers by Mohammad Ali Mashhadi
This network shows the impact of papers produced by Mohammad Ali Mashhadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Ali Mashhadi. The network helps show where Mohammad Ali Mashhadi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mohammad Ali Mashhadi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 3 | |
| 2 | Cisplatin Induce Changes of Cell Surface Glycoconjugates in Germinal Epithelium of Seminiferous Tubules | 2018 | 3 |
| 3 | 2017 | 18 | |
| 4 | 2016 | 8 | |
| 5 | Toxic Effects of Cisplatin on Hepatocytes and Liver Enzymes of Rats | 2015 | 19 |
| 6 | 2014 | 13 | |
| 7 | Copper Status in Patients with Thalassemia Major in Zahedan, Iran | 2013 | 3 |
| 8 | High Dose Methotrexat Liver Toxicity | 2011 | 1 |
| 9 | The Best Iron Chelation Therapy in Major Thalassemia Patients is Combination of Desferrioxamine and Deferiprone | 2011 | 1 |
| 10 | IEV (Ifosfamide, Epirubicin, VP16) Regimen as Salvage Therapy for Early Relapsed/Refractory non-Hodgkin/Hodgkin Lymphoma | 2011 | 1 |
| 11 | High Prevalence of Esophageal Cancer in South East of Iran | 2011 | 4 |
| 12 | VAD Regimen as Initial Treatment for Multiple Myeloma | 2010 | 1 |
| 13 | Cancer Incidence in South East of Iran: Results of a Population-Based Cancer Registry | 2010 | 15 |
| 14 | Neuropsychiatric Toxicity of Ifosfamide in Patients Admitted for Chemotherapy | 2010 | 0 |
| 15 | Gastric Cancer in South East of Iran | 2009 | 3 |
| 16 | Evaluation of response, tolerability and toxicity of new chemotherapeutic regimen in advanced Gastric Cancer | 2009 | 1 |
| 17 | Pregnancy Outcome of Two Patients with Chronic Myelogenous Leukemia Treated with Imatinib | 2008 | 1 |
| 18 | AUTOLOGOUS STEM CELL TRANSPLANTATION WITH MODERATE DOSE OF IDARUBICIN AND BUSULPHAN AS CONDITIONING REGIMEN IN ACUTE MYELOGENOUS LEUKEMIA | 2008 | 1 |
| 19 | RENAL SIDE EFFECTS OF IFOSFAMIDE IN PATIENTS ADMITTED FOR CHEMOTHERAPY | 2008 | 5 |
| 20 | THE EFFECTS OF HIGH DOSE METHOTREXATE IN PATIENTS WITH NEOPLASTIC DISEASES: A PROSPECTIVE STUDY | 2008 | 3 |
About Mohammad Ali Mashhadi
Mohammad Ali Mashhadi is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 67 papers that have together received 840 indexed citations. Recurring topics across this work include Iron Metabolism and Disorders (8 papers), Hemoglobinopathies and Related Disorders (7 papers), Trace Elements in Health (6 papers), Chemotherapy-induced organ toxicity mitigation (6 papers), Vitamin D Research Studies (5 papers), Gastric Cancer Management and Outcomes (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). The work is most often cited by research in Hematology (117 citations), Cancer Research (154 citations) and Genetics (76 citations). Mohammad Ali Mashhadi has collaborated with scholars based in Iran, Canada and Sweden. Frequent co-authors include Mohammad Hashemi, Mohsen Taheri, Ebrahim Eskandari‐Nasab, Aliakbar Fazaeli, Mohsen Omrani, Mahmoud Ali Kaykhaei, Zahra Sepehri, Seyed Mehdi Hashemi, Hamzeh Rezaei and Saeid Ghavami. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.